Annotation (Toggle Detail/Summary View) Gene-Chemical Interaction AnnotationsTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:1316466 | 6480464 | Dinitrochlorobenzene results in increased expression of SRXN1 mRNA | CTD | PMID:20566472 | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of SRXN1 mRNA | CTD | PMID:20551477 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of SRXN1 mRNA | CTD | PMID:17351261 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1614270 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SRXN1 mRNA | CTD | PMID:17942748 | 17beta-estradiol | increases expression | ISO | RGD:1316466 | 6480464 | Estradiol results in increased expression of SRXN1 mRNA | CTD | PMID:20106945 | 17beta-estradiol | affects expression | ISO | RGD:1316466 | 6480464 | Estradiol affects the expression of SRXN1 mRNA | CTD | PMID:22574217 | 1H-pyrazole | increases expression | ISO | RGD:1614270 | 6480464 | pyrazole results in increased expression of SRXN1 mRNA | CTD | PMID:17945193 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:1614270 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of SRXN1 mRNA]; more ... | CTD | PMID:21851831 | 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | RGD:1614270 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of SRXN1 mRNA | CTD | PMID:21851831 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1614270 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SRXN1 mRNA | CTD | PMID:18796159 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1614270 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SRXN1 mRNA | CTD | PMID:20702594 PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1316466 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SRXN1 mRNA | CTD | PMID:20106945 PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1614270 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of SRXN1 mRNA]; more ... | CTD | PMID:21851831 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1614270 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SRXN1 mRNA | CTD | PMID:18796159 PMID:21851831 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1614270 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SRXN1 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1614270 | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of SRXN1 mRNA | CTD | PMID:16214954 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1614270 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SRXN1 mRNA | CTD | PMID:20702594 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1316466 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SRXN1 mRNA | CTD | PMID:20106945 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SRXN1 mRNA | CTD | PMID:18796159 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of SRXN1 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of SRXN1 mRNA | CTD | PMID:21346803 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1614270 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SRXN1 mRNA | CTD | PMID:20188158 | 4-hydroxynon-2-enal | increases expression | ISO | RGD:1614270 | 6480464 | 4-hydroxy-2-nonenal results in increased expression of SRXN1 mRNA | CTD | PMID:19191707 | 4-hydroxynon-2-enal | increases expression | ISO | RGD:1614270 | 6480464 | 4-hydroxy-2-nonenal results in increased expression of SRXN1 mRNA | CTD | PMID:19191707 PMID:22003191 | 4-nitrophenol | increases expression | ISO | RGD:1614270 | 6480464 | 4-nitrophenol results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | 4-nitroquinoline N-oxide | increases expression | ISO | RGD:1614270 | 6480464 | 4-Nitroquinoline-1-oxide results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | aflatoxin B1 | affects expression | ISO | RGD:1316466 | 6480464 | Aflatoxin B1 affects the expression of SRXN1 protein | CTD | PMID:20106945 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of SRXN1 mRNA | CTD | PMID:22484513 | aflatoxin B1 | increases expression | ISO | RGD:1316466 | 6480464 | Aflatoxin B1 results in increased expression of SRXN1 mRNA | CTD | PMID:22100608 | aflatoxin B1 | decreases expression | ISO | RGD:1614270 | 6480464 | Aflatoxin B1 results in decreased expression of SRXN1 mRNA | CTD | PMID:19770486 | alpha-hexylcinnamaldehyde | increases expression | ISO | RGD:1316466 | 6480464 | hexyl cinnamic aldehyde results in increased expression of SRXN1 mRNA | CTD | PMID:20566472 | ampicillin | decreases expression | ISO | RGD:1316466 | 6480464 | Ampicillin results in decreased expression of SRXN1 mRNA | CTD | PMID:21632981 | andrographolide | multiple interactions | ISO | RGD:1614270 | 6480464 | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of SRXN1 mRNA | CTD | PMID:19737545 | andrographolide | increases expression | ISO | RGD:1614270 | 6480464 | andrographolide results in increased expression of SRXN1 mRNA | CTD | PMID:19737545 | aphidicolin | increases expression | ISO | RGD:1614270 | 6480464 | Aphidicolin results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | arsenic atom | multiple interactions | ISO | RGD:1614270 | 6480464 | NFE2L2 mRNA affects the reaction [Arsenic results in increased expression of SRXN1 mRNA] | CTD | PMID:23000044 | arsenic atom | increases expression | ISO | RGD:1614270 | 6480464 | Arsenic results in increased expression of SRXN1 mRNA | CTD | PMID:23000044 | arsenite(3-) | increases expression | ISO | RGD:1316466 | 6480464 | arsenite results in increased expression of SRXN1 mRNA | CTD | PMID:22476201 | arsenite(3-) | multiple interactions | ISO | RGD:1316466 | 6480464 | KEAP1 protein affects the reaction [arsenite results in increased expression of SRXN1 mRNA]; more ... | CTD | PMID:22476201 | Bandrowski's base | increases expression | ISO | RGD:1316466 | 6480464 | Bandrowski's base results in increased expression of SRXN1 mRNA | CTD | PMID:20566472 | benzo[a]pyrene | increases expression | ISO | RGD:1614270 | 6480464 | Benzo(a)pyrene results in increased expression of SRXN1 mRNA | CTD | PMID:19770486 PMID:21715664 | benzo[a]pyrene | increases expression | ISO | RGD:1316466 | 6480464 | Benzo(a)pyrene results in increased expression of SRXN1 mRNA | CTD | PMID:20106945 more ... | benzo[a]pyrene | increases expression | ISO | RGD:1316466 | 6480464 | Benzo(a)pyrene results in increased expression of SRXN1 mRNA | CTD | PMID:20106945 PMID:22316170 | benzo[a]pyrene | increases expression | ISO | RGD:1614270 | 6480464 | Benzo(a)pyrene results in increased expression of SRXN1 mRNA | CTD | PMID:19770486 more ... | benzo[a]pyrene | increases expression | ISO | RGD:1614270 | 6480464 | Benzo(a)pyrene results in increased expression of SRXN1 mRNA | CTD | PMID:19770486 more ... | benzo[a]pyrene | increases expression | ISO | RGD:1614270 | 6480464 | Benzo(a)pyrene results in increased expression of SRXN1 mRNA | CTD | PMID:21715664 more ... | benzo[a]pyrene | increases expression | ISO | RGD:1614270 | 6480464 | Benzo(a)pyrene results in increased expression of SRXN1 mRNA | CTD | PMID:21715664 PMID:19770486 | benzo[a]pyrene | increases expression | ISO | RGD:1614270 | 6480464 | Benzo(a)pyrene results in increased expression of SRXN1 mRNA | CTD | PMID:21715664 | benzo[a]pyrene | increases expression | ISO | RGD:1316466 | 6480464 | Benzo(a)pyrene results in increased expression of SRXN1 mRNA | CTD | PMID:20106945 | benzo[a]pyrene | multiple interactions | ISO | RGD:1614270 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of SRXN1 mRNA | CTD | PMID:21715664 | benzoic acid | increases expression | ISO | RGD:1316466 | 6480464 | Benzoic Acid results in increased expression of SRXN1 mRNA | CTD | PMID:20566472 | bleomycin A2 | increases expression | ISO | RGD:1614270 | 6480464 | Bleomycin results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | cadmium atom | increases expression | ISO | RGD:1316466 | 6480464 | Cadmium results in increased expression of SRXN1 mRNA | CTD | PMID:21172416 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of SRXN1 mRNA | CTD | PMID:19010381 | cadmium dichloride | increases expression | ISO | RGD:1614270 | 6480464 | Cadmium Chloride results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 PMID:22677785 | cadmium dichloride | multiple interactions | ISO | RGD:1614270 | 6480464 | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [Cadmium Chloride results in increased expression of SRXN1 mRNA]; more ... | CTD | PMID:22003191 | cadmium dichloride | increases expression | ISO | RGD:1614270 | 6480464 | Cadmium Chloride results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | cadmium dichloride | affects expression | ISO | RGD:1614270 | 6480464 | Cadmium Chloride affects the expression of SRXN1 mRNA | CTD | PMID:18974090 | cadmium sulfate | increases expression | ISO | RGD:1614270 | 6480464 | cadmium sulfate results in increased expression of SRXN1 mRNA | CTD | PMID:16221973 | camptothecin | increases expression | ISO | RGD:1614270 | 6480464 | Camptothecin results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of SRXN1 mRNA | CTD | PMID:23125180 | chloroprene | increases expression | ISO | RGD:1614270 | 6480464 | Chloroprene results in increased expression of SRXN1 mRNA | CTD | PMID:23125180 | choline | multiple interactions | ISO | RGD:1614270 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SRXN1 mRNA | CTD | PMID:20938992 | ciglitazone | increases expression | EXP | | 6480464 | ciglitazone results in increased expression of SRXN1 mRNA | CTD | PMID:22193206 | cinnamyl alcohol | increases expression | ISO | RGD:1316466 | 6480464 | cinnamyl alcohol results in increased expression of SRXN1 mRNA | CTD | PMID:20566472 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of SRXN1 mRNA | CTD | PMID:22023808 | cisplatin | increases expression | ISO | RGD:1614270 | 6480464 | Cisplatin results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | cisplatin | increases expression | ISO | RGD:1316466 | 6480464 | Cisplatin results in increased expression of SRXN1 mRNA | CTD | PMID:19561079 | cobalt dichloride | increases expression | ISO | RGD:1316466 | 6480464 | cobaltous chloride results in increased expression of SRXN1 mRNA | CTD | PMID:19320972 | copper atom | increases expression | ISO | RGD:1316466 | 6480464 | Copper results in increased expression of SRXN1 mRNA | CTD | PMID:19747488 | copper atom | multiple interactions | ISO | RGD:1316466 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of SRXN1 mRNA | CTD | PMID:20971185 | copper atom | multiple interactions | ISO | RGD:1316466 | 6480464 | N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [Copper results in increased expression of SRXN1 mRNA]; more ... | CTD | PMID:19747488 | copper(0) | increases expression | ISO | RGD:1316466 | 6480464 | Copper results in increased expression of SRXN1 mRNA | CTD | PMID:19747488 | copper(0) | multiple interactions | ISO | RGD:1316466 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of SRXN1 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RGD:1316466 | 6480464 | N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [Copper results in increased expression of SRXN1 mRNA]; more ... | CTD | PMID:19747488 | copper(2+) sulfate | increases expression | ISO | RGD:1316466 | 6480464 | Copper Sulfate results in increased expression of SRXN1 mRNA | CTD | PMID:19549813 | copper(2+) sulfate | multiple interactions | ISO | RGD:1614270 | 6480464 | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [Copper Sulfate results in increased expression of SRXN1 mRNA]; more ... | CTD | PMID:22003191 | copper(2+) sulfate | increases expression | ISO | RGD:1614270 | 6480464 | Copper Sulfate results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | coumarin | increases expression | EXP | | 6480464 | coumarin results in increased expression of SRXN1 mRNA | CTD | PMID:18480146 | cyclosporin A | increases expression | ISO | RGD:1316466 | 6480464 | Cyclosporine results in increased expression of SRXN1 mRNA | CTD | PMID:20106945 | cyclosporin A | increases expression | ISO | RGD:1316466 | 6480464 | Cyclosporine results in increased expression of SRXN1 mRNA | CTD | PMID:20106945 PMID:21632981 | cypermethrin | increases expression | ISO | RGD:1614270 | 6480464 | cypermethrin results in increased expression of SRXN1 mRNA | CTD | PMID:21142847 | cytarabine | increases expression | ISO | RGD:1614270 | 6480464 | Cytarabine results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:1614270 | 6480464 | Tetrahydrocannabinol results in increased expression of SRXN1 mRNA | CTD | PMID:21542829 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of SRXN1 mRNA | CTD | PMID:21266533 | diethyl maleate | increases expression | ISO | RGD:1614270 | 6480464 | diethyl maleate results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | diethyl maleate | multiple interactions | ISO | RGD:1614270 | 6480464 | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [diethyl maleate results in increased expression of SRXN1 mRNA]; more ... | CTD | PMID:22003191 | dimethyl sulfoxide | increases expression | EXP | | 6480464 | Dimethyl Sulfoxide results in increased expression of SRXN1 mRNA | CTD | PMID:22193206 | diquat | increases expression | ISO | RGD:1316466 | 6480464 | Diquat results in increased expression of SRXN1 mRNA | CTD | PMID:21172416 | disulfiram | increases expression | ISO | RGD:1316466 | 6480464 | Disulfiram results in increased expression of SRXN1 mRNA | CTD | PMID:20566472 | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of SRXN1 mRNA | CTD | PMID:21551480 | doxorubicin | increases expression | ISO | RGD:1614270 | 6480464 | Doxorubicin results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | ethanol | increases expression | ISO | RGD:1614270 | 6480464 | Ethanol results in increased expression of SRXN1 mRNA | CTD | PMID:19167417 | etoposide | increases expression | ISO | RGD:1614270 | 6480464 | Etoposide results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | eugenol | increases expression | ISO | RGD:1316466 | 6480464 | Eugenol results in increased expression of SRXN1 mRNA | CTD | PMID:20566472 | folic acid | multiple interactions | ISO | RGD:1614270 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SRXN1 mRNA | CTD | PMID:20938992 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of SRXN1 mRNA | CTD | PMID:20884683 PMID:18499655 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of SRXN1 mRNA | CTD | PMID:18499655 PMID:20884683 | fumonisin B1 | increases expression | ISO | RGD:1614270 | 6480464 | fumonisin B1 results in increased expression of SRXN1 mRNA | CTD | PMID:16221962 | genistein | increases expression | ISO | RGD:1316466 | 6480464 | Genistein results in increased expression of SRXN1 mRNA | CTD | PMID:18847459 | glutathione | increases expression | EXP | | 6480464 | Glutathione deficiency results in increased expression of SRXN1 mRNA | CTD | PMID:20621112 | hexane | increases expression | ISO | RGD:1316466 | 6480464 | n-hexane results in increased expression of SRXN1 mRNA | CTD | PMID:20566472 | hydralazine | multiple interactions | ISO | RGD:1316466 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SRXN1 mRNA | CTD | PMID:17183730 | hydrogen peroxide | affects expression | ISO | RGD:1316466 | 6480464 | Hydrogen Peroxide affects the expression of SRXN1 mRNA | CTD | PMID:20044591 | hydrogen peroxide | increases expression | ISO | RGD:1614270 | 6480464 | Hydrogen Peroxide results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | hydroxyurea | increases expression | ISO | RGD:1614270 | 6480464 | Hydroxyurea results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | hypochlorous acid | increases expression | ISO | RGD:1614270 | 6480464 | Hypochlorous Acid results in increased expression of SRXN1 mRNA | CTD | PMID:19376150 | isoeugenol | increases expression | ISO | RGD:1316466 | 6480464 | isoeugenol results in increased expression of SRXN1 mRNA | CTD | PMID:20566472 | L-methionine | multiple interactions | ISO | RGD:1614270 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SRXN1 mRNA | CTD | PMID:20938992 | lactic acid | increases expression | ISO | RGD:1316466 | 6480464 | Lactic Acid results in increased expression of SRXN1 mRNA | CTD | PMID:20566472 | methyl methacrylate | increases expression | ISO | RGD:1614270 | 6480464 | Methylmethacrylate results in increased expression of SRXN1 mRNA | CTD | PMID:16916219 | methyl methanesulfonate | increases expression | ISO | RGD:1614270 | 6480464 | Methyl Methanesulfonate results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | methyl methanesulfonate | multiple interactions | ISO | RGD:1614270 | 6480464 | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [Methyl Methanesulfonate results in increased expression of SRXN1 mRNA]; more ... | CTD | PMID:22003191 | methyl salicylate | increases expression | ISO | RGD:1316466 | 6480464 | methyl salicylate results in increased expression of SRXN1 mRNA | CTD | PMID:20566472 | mitomycin C | increases expression | ISO | RGD:1614270 | 6480464 | Mitomycin results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | morphine | increases expression | ISO | RGD:1614270 | 6480464 | Morphine results in increased expression of SRXN1 mRNA | CTD | PMID:20144693 | N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1614270 | 6480464 | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [diethyl maleate results in increased expression of SRXN1 mRNA]; more ... | CTD | PMID:22003191 | N-methylformamide | affects expression | ISO | RGD:1614270 | 6480464 | methylformamide affects the expression of SRXN1 mRNA; more ... | CTD | PMID:17040096 | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of SRXN1 mRNA | CTD | PMID:19638242 | nickel sulfate | increases expression | ISO | RGD:1316466 | 6480464 | nickel sulfate results in increased expression of SRXN1 mRNA | CTD | PMID:20566472 | ozone | increases expression | ISO | RGD:1614270 | 6480464 | Ozone results in increased expression of SRXN1 mRNA | CTD | PMID:17095637 | paclitaxel | increases expression | ISO | RGD:1614270 | 6480464 | Paclitaxel results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | paracetamol | affects expression | ISO | RGD:1614270 | 6480464 | Acetaminophen affects the expression of SRXN1 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | RGD:1316466 | 6480464 | Acetaminophen results in increased expression of SRXN1 mRNA | CTD | PMID:21420995 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SRXN1 mRNA | CTD | PMID:17202762 | paraquat | multiple interactions | ISO | RGD:1614270 | 6480464 | APOD protein affects the reaction [Paraquat results in increased expression of SRXN1 mRNA] | CTD | PMID:21688324 | paraquat | increases expression | ISO | RGD:1614270 | 6480464 | Paraquat results in increased expression of SRXN1 mRNA | CTD | PMID:21688324 | phenobarbital | increases expression | ISO | RGD:1614270 | 6480464 | Phenobarbital results in increased expression of SRXN1 mRNA | CTD | PMID:19482888 PMID:19270015 | phenobarbital | increases expression | ISO | RGD:1614270 | 6480464 | Phenobarbital results in increased expression of SRXN1 mRNA | CTD | PMID:19270015 more ... | phenobarbital | affects expression | ISO | RGD:1316466 | 6480464 | Phenobarbital affects the expression of SRXN1 mRNA | CTD | PMID:19159669 | phenobarbital | increases expression | ISO | RGD:1614270 | 6480464 | Phenobarbital results in increased expression of SRXN1 mRNA | CTD | PMID:19270015 PMID:19482888 | phenobarbital | affects expression | ISO | RGD:1614270 | 6480464 | Phenobarbital affects the expression of SRXN1 mRNA | CTD | PMID:19136022 | phenobarbital | multiple interactions | ISO | RGD:1614270 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SRXN1 mRNA] | CTD | PMID:19482888 | phorone | affects expression | EXP | | 6480464 | phorone affects the expression of SRXN1 mRNA | CTD | PMID:18198479 | piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of SRXN1 mRNA | CTD | PMID:22484513 | pirinixic acid | affects expression | ISO | RGD:1614270 | 6480464 | pirinixic acid affects the expression of SRXN1 mRNA | CTD | PMID:19136022 | pirinixic acid | increases expression | ISO | RGD:1614270 | 6480464 | pirinixic acid results in increased expression of SRXN1 mRNA | CTD | PMID:16221962 more ... | pirinixic acid | increases expression | ISO | RGD:1614270 | 6480464 | pirinixic acid results in increased expression of SRXN1 mRNA | CTD | PMID:16221962 more ... | pirinixic acid | increases expression | ISO | RGD:1614270 | 6480464 | pirinixic acid results in increased expression of SRXN1 mRNA | CTD | PMID:20059764 more ... | pirinixic acid | multiple interactions | ISO | RGD:1614270 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of SRXN1 mRNA] | CTD | PMID:20059764 | pirinixic acid | multiple interactions | ISO | RGD:1614270 | 6480464 | PPARA protein affects the reaction [pirinixic acid results in increased expression of SRXN1 mRNA] | CTD | PMID:16221962 | pirinixic acid | increases expression | ISO | RGD:1614270 | 6480464 | pirinixic acid results in increased expression of SRXN1 mRNA | CTD | PMID:18301758 more ... | pirinixic acid | decreases expression | ISO | RGD:1614270 | 6480464 | pirinixic acid results in decreased expression of SRXN1 mRNA | CTD | PMID:20813756 | potassium bromate | increases expression | ISO | RGD:1614270 | 6480464 | potassium bromate results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | propan-2-ol | increases expression | ISO | RGD:1316466 | 6480464 | 2-Propanol results in increased expression of SRXN1 mRNA | CTD | PMID:20566472 | propiconazole | increases expression | ISO | RGD:1614270 | 6480464 | propiconazole results in increased expression of SRXN1 mRNA | CTD | PMID:21278054 | propiconazole | increases expression | ISO | RGD:1614270 | 6480464 | propiconazole results in increased expression of SRXN1 mRNA | CTD | PMID:21278054 PMID:22334560 | quercetin | affects expression | EXP | | 6480464 | Quercetin affects the expression of SRXN1 mRNA | CTD | PMID:18178720 | quinolin-8-ol | increases expression | ISO | RGD:1316466 | 6480464 | Oxyquinoline results in increased expression of SRXN1 mRNA | CTD | PMID:21632981 | resorcinol | increases expression | ISO | RGD:1614270 | 6480464 | resorcinol results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | silicon dioxide | increases expression | ISO | RGD:1614270 | 6480464 | Silicon Dioxide results in increased expression of SRXN1 mRNA | CTD | PMID:19073995 | silver atom | affects expression | ISO | RGD:1614270 | 6480464 | Silver affects the expression of SRXN1 mRNA | CTD | PMID:19429238 | silver(0) | affects expression | ISO | RGD:1614270 | 6480464 | Silver affects the expression of SRXN1 mRNA | CTD | PMID:19429238 | sodium dodecyl sulfate | increases expression | ISO | RGD:1316466 | 6480464 | Sodium Dodecyl Sulfate results in increased expression of SRXN1 mRNA | CTD | PMID:20566472 | succimer | multiple interactions | ISO | RGD:1614270 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SRXN1 mRNA | CTD | PMID:21641980 | sulfisoxazole | increases expression | ISO | RGD:1614270 | 6480464 | Sulfisoxazole results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | tert-butyl hydroperoxide | increases expression | ISO | RGD:1614270 | 6480464 | tert-Butylhydroperoxide results in increased expression of SRXN1 mRNA | CTD | PMID:22003191 | tetrachloromethane | affects expression | ISO | RGD:1614270 | 6480464 | Carbon Tetrachloride affects the expression of SRXN1 mRNA | CTD | PMID:17484886 | trichloroethene | increases expression | ISO | RGD:1614270 | 6480464 | Trichloroethylene results in increased expression of SRXN1 mRNA | CTD | PMID:19448997 | troglitazone | increases expression | ISO | RGD:1316466 | 6480464 | troglitazone results in increased expression of SRXN1 mRNA | CTD | PMID:19140230 | valproic acid | multiple interactions | ISO | RGD:1316466 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SRXN1 mRNA | CTD | PMID:17183730 | |
Gene Ontology AnnotationsBiological Process




